Identifying a targeted population at high risk for infections after liver transplantation in the MELD era

被引:38
|
作者
Sun, Hsin-Yun [2 ,3 ]
Cacciarelli, Thomas V. [2 ]
Singh, Nina [1 ,2 ]
机构
[1] Univ Pittsburgh, VA Med Ctr, Infect Dis Sect, Pittsburgh, PA 15240 USA
[2] Natl Taiwan Univ Hosp, Vet Affair Pittsburgh Healthcare Syst, Taipei, Taiwan
[3] Natl Taiwan Univ Hosp, Dept Internal Med, Taipei, Taiwan
关键词
D-model for end-stage liver disease; liver transplant; model for end-stage liver disease; mortality; post-transplant dialysis; post-transplant infection; INVASIVE FUNGAL-INFECTIONS; PREEMPTIVE THERAPY; RECIPIENTS; ALLOCATION; MORTALITY; DISEASE; TRENDS; IMPACT; DONOR; CYTOMEGALOVIRUS;
D O I
10.1111/j.1399-0012.2010.01262.x
中图分类号
R61 [外科手术学];
学科分类号
摘要
Impact of model for end-stage liver disease (MELD) scoring system on post-transplant infections and associated risk factors are unknown. Infections < 90 d post-transplant were assessed in 277 consecutive liver transplant recipients from 1999 to 2008. "High-risk" factors for infections were pre-defined as MELD score > 30, ICU stay > 48 h prior to transplant, intraoperative transfusion >= 15 units, retransplantation, post-transplant dialysis, or reoperation. Of the 240 recipients in the MELD era (2002-2008), 48.5% had any high-risk factor. The OR for infection was 1.69, 2.00, 18.00, and 4.50 in recipients with any 1, 2, 3, and >= 4 high-risk factors, respectively (chi 2 for trend, p < 0.001). In logistic regression model, recipient age (OR 1.12, p < 0.05) and any high-risk factor (OR 2.42, p < 0.05) were associated with infections. Compared with 37 pre-MELD recipients, the overall infections and mortality at 12 months did not differ in the two eras. In Cox regression model, recipient age (OR 1.09, p < 0.05) and any high-risk factor (OR 2.42, p < 0.05) remained associated with infections. The overall frequency of infections did not increase in the MELD era. Pre-defined risk factors accurately predicted the risk of infections in these patients.
引用
收藏
页码:420 / 425
页数:6
相关论文
共 50 条
  • [41] Impact of dynamic changes in MELD score on survival after liver transplantation - a Eurotransplant registry analysis
    Gyoeri, Georg P.
    Silberhumer, Gerd R.
    Rahmel, Axel
    de Vries, Erwin
    Soliman, Thomas
    Zehetmayer, Sonja
    Rogiers, Xavier
    Berlakovich, Gabriela A.
    LIVER INTERNATIONAL, 2016, 36 (07) : 1011 - 1017
  • [42] Comprehensive risk assessment for early neurologic complications after liver transplantation
    Wu, Si-Yuan
    Chen, Teng-Wei
    Feng, An-Chieh
    Fan, Hsiu-Lung
    Hsieh, Chung-Bao
    Chung, Kuo-Piao
    WORLD JOURNAL OF GASTROENTEROLOGY, 2016, 22 (24) : 5548 - 5557
  • [43] Intraoperative risk factors of acute kidney injury after liver transplantation
    Berkowitz, Rachel J.
    Engoren, Milo C.
    Mentz, Graciela
    Sharma, Pratima
    Kumar, Sathish S.
    Davis, Ryan
    Kheterpal, Sachin
    Sonnenday, Christopher J.
    Douville, Nicholas J.
    LIVER TRANSPLANTATION, 2022, 28 (07) : 1207 - 1223
  • [44] Incidence and risk factors of opportunistic infections after autologous stem cell transplantation: a nationwide, population-based cohort study in Korea
    Kim, Da Jung
    Jeong, Seri
    Kong, Seom Gim
    Lee, Sangjin
    Lim, Sung-Nam
    Oh, Sung Yong
    Do, Young Rok
    Lee, Won Sik
    Lee, Mark Hong
    Bae, Sung Hwa
    Kim, Se Hyung
    Kim, Min Kyoung
    Lee, Ho Sup
    SCIENTIFIC REPORTS, 2023, 13 (01)
  • [45] Invasive Fungal Infections after Liver Transplantation
    Senoner, Thomas
    Breitkopf, Robert
    Treml, Benedikt
    Rajsic, Sasa
    JOURNAL OF CLINICAL MEDICINE, 2023, 12 (09)
  • [46] Should All Status 1A Patients Be Prioritized Over High MELD Patients? Concept of Risk Stratification in Extremely Ill Liver Transplant Recipients
    Safwan, Mohamed
    Nwagu, Uche
    Collins, Kelly
    Abouljoud, Marwan
    Nagai, Shunji
    TRANSPLANTATION, 2019, 103 (10) : 2121 - 2129
  • [47] Multidrug-Resistant Infections After Liver Transplantation, Etiology and Risk Factors: A Single-Center Experience
    Tezcan, Hatice
    Altunsoy, Adalet
    Gokce, Dilara Turan
    Gokcan, Hale
    Ari, Derya
    Aydin, Osman
    Bostanci, Erdal Birol
    Kayhan, Meral Akdogan
    EXPERIMENTAL AND CLINICAL TRANSPLANTATION, 2023, 21 (12) : 952 - 960
  • [48] A Universal Preemptive Therapy for Cytomegalovirus Infections in Children After Live-Donor Liver Transplantation
    Saitoh, Akihiko
    Sakamoto, Seisuke
    Fukuda, Akinari
    Shigeta, Takanobu
    Kakiuchi, Toshihiko
    Kamiyama, Shinya
    Katsuta, Tomohiro
    Shoji, Kensuke
    Ogimi, Chikara
    Kasahara, Mureo
    TRANSPLANTATION, 2011, 92 (08) : 930 - 935
  • [49] Impact of MELD-Based Allocation on End-Stage Renal Disease After Liver Transplantation
    Sharma, P.
    Schaubel, D. E.
    Guidinger, M. K.
    Goodrich, N. P.
    Ojo, A. O.
    Merion, R. M.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2011, 11 (11) : 2372 - 2378
  • [50] A Comprehensive Review on the Risk of Metabolic Syndrome and Cardiovascular Disease after Liver Transplantation
    Chauhan, Kashyap
    Khan, Adnan
    Chowdhury, Salil
    Ross, Heather M.
    Parra, Natalia Salinas
    Halegoua-DeMarzio, Dina
    LIVERS, 2022, 2 (02): : 85 - 96